GC Aesthetics, a medical technology company providing women’s healthcare aesthetic and reconstructive solutions, has announced its growth and expansion plans for the Brazilian market, the second largest breast augmentation market in the world.
The company’s Brazilian growth strategy includes two main pillars: First, the commercialization of all GC Aesthetics products and technologies designed to support the best outcome for women’s breast enhancement journey, before, during, and after surgery. This portfolio not only stands out in today’s industry but is aligned with the company leadership position and growing plans evolving from breast implant manufacturers to solution providers, GC Aesthetics officials say.
The Brazilian revenue growth of GC Aesthetics is also linked to the ANVISA certificate (Brazilian Health Regulatory Agency) just obtained for the re-introduction of The Round Collection™ breast implants. This microtextured surface breast implant has been the preferred option by surgeons in Brazil: 99% of surveyed plastic surgeons consider The Round Collection as a top product in terms of safety and performance.
“According to our most recent survey, long-term proven safety and the unique type of micro texture are the two top reasons Brazilian plastic surgeons prefer The Round Collection Implants against competitors,” says GC Aesthetics’ CEO Carlos Reis Pinto. “We are beyond excited to be back in Brazil with this product and offer surgeons and patients a proven long-term, safe, and reliable medical device. Pre-orders of this product have exceeded what we had planned, and we are looking forward to a very bright, leading future in Brazil and in the world.”
GC Aesthetics will be presenting the re-introduction of this product to the Brazilian at the Jornada Paulista de Cirurgia Plástica, held this week at the WTC São Paulo.
